... -2011 — Journal of Acquired Immune Deficiency Syndromes
Decreasing Prevalence and Stagnating Incidence of Hepatitis C — Co-Infection Among a Cohort of HIV-1-Positive Patients, With a Majority of Men Who Have Sex With Men, in Germany, 1996-2019 — Journal of Viral Hepatitis
Epidemiological Trends of HIV/HCV Coinfection in Spain, 2015-2019 — HIV Medicine ...
Envejecer con VIH: 5 problemas que debe vigilar
... -2011 — Journal of Acquired Immune Deficiency Syndromes
Decreasing Prevalence and Stagnating Incidence of Hepatitis C — Co-Infection Among a Cohort of HIV-1-Positive Patients, With a Majority of Men Who Have Sex With Men, in Germany, 1996-2019 — Journal of Viral Hepatitis
Epidemiological Trends of HIV/HCV Coinfection in Spain, 2015-2019 — HIV Medicine ...
... Sleep: A Review of the Literature — Current Psychiatry Reports
Chronic Insomnia as a Risk Factor for Developing Anxiety and Depression — Sleep
Cannabidiol in Anxiety and Sleep: A Large Case Series — The Permanente Journal
Sleep Deficiency and Chronic Pain: Potential Underlying Mechanisms and Clinical Implications — Neuropsychopharmacology
Cannabis-Based ...
Marihuana médica y VIH: ¿puede ayudar?
... Sleep: A Review of the Literature — Current Psychiatry Reports
Chronic Insomnia as a Risk Factor for Developing Anxiety and Depression — Sleep
Cannabidiol in Anxiety and Sleep: A Large Case Series — The Permanente Journal
Sleep Deficiency and Chronic Pain: Potential Underlying Mechanisms and Clinical Implications — Neuropsychopharmacology
Cannabis-Based ...
... Cannabidiolic Acid, and Cannabidiolic Acid Methyl Ester as Treatments for Nausea and Vomiting — Cannabis and Cannabinoid Research
Cannabidiol (CBD) in Cancer Management — Cancers
Anxiety — Medical Cannabis and CBD in Mental Healthcare
Cannabidiol Adverse Effects and Toxicity — Current Neuropharmacology
Potential Adverse Drug Events and Drug-Drug Interactions With ...
CBD para el VIH: ¿es eficaz?
... Cannabidiolic Acid, and Cannabidiolic Acid Methyl Ester as Treatments for Nausea and Vomiting — Cannabis and Cannabinoid Research
Cannabidiol (CBD) in Cancer Management — Cancers
Anxiety — Medical Cannabis and CBD in Mental Healthcare
Cannabidiol Adverse Effects and Toxicity — Current Neuropharmacology
Potential Adverse Drug Events and Drug-Drug Interactions With ...
... You Have Sex With That You Have HIV — Aidsmap
PrEP (Pre-Exposure Prophylaxis) — Centers for Disease Control and Prevention
Cabenuva: Dosing and Administration Guide — ViiV Healthcare
Male (External) Condom Use — Centers for Disease Control and Prevention ...
Cómo encarar los vínculos románticos con VIH
... You Have Sex With That You Have HIV — Aidsmap
PrEP (Pre-Exposure Prophylaxis) — Centers for Disease Control and Prevention
Cabenuva: Dosing and Administration Guide — ViiV Healthcare
Male (External) Condom Use — Centers for Disease Control and Prevention ...
... tratamiento del VIH — HIVinfo.NIH.gov
Antiretroviral Therapy — Cleveland Clinic
HIV Resistance Testing — International Association of Providers of AIDS Care
HIV Drug Resistance — World Health Organization
Virologic Failure — HIVinfo.NIH.gov
HIV Drug Resistance — HIVinfo.NIH.gov
Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents With ...
Resistencia farmacológica al VIH: Mutaciones, pruebas, síntomas, y más
... tratamiento del VIH — HIVinfo.NIH.gov
Antiretroviral Therapy — Cleveland Clinic
HIV Resistance Testing — International Association of Providers of AIDS Care
HIV Drug Resistance — World Health Organization
Virologic Failure — HIVinfo.NIH.gov
HIV Drug Resistance — HIVinfo.NIH.gov
Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents With ...
... Discovery From the First Cases of a Mysterious Disease in the Early 1980s — Institut Pasteur
The Tragic History of AIDS in the Hemophilia Population, 1982–1984 — Journal of Thrombosis and Haemostasis
HAART: A Boon to Mankind — Frontiers in Clinical Drug Research: HIV
FDA Continues To Encourage Ongoing Education About Benefits and Risks Associated With ...
¿Qué es el virus de la inmunodeficiencia humana? Qué hace y más
... Discovery From the First Cases of a Mysterious Disease in the Early 1980s — Institut Pasteur
The Tragic History of AIDS in the Hemophilia Population, 1982–1984 — Journal of Thrombosis and Haemostasis
HAART: A Boon to Mankind — Frontiers in Clinical Drug Research: HIV
FDA Continues To Encourage Ongoing Education About Benefits and Risks Associated With ...
... Life Expectancy and Mental Related Burden of Disease Among People Living With HIV/AIDS — AIDS Care
...
... El riesgo aumenta si la persona que realiza el sexo oral tiene otra ITS (como el herpes), o si hay semen en la boca y la persona tiene encías sangrantes, llagas en la boca o úlceras genitales.¿Cómo se pueden prevenir el herpes y el VIH? ...
Herpes vs. VIH: ¿Cuál es la diferencia?
... El riesgo aumenta si la persona que realiza el sexo oral tiene otra ITS (como el herpes), o si hay semen en la boca y la persona tiene encías sangrantes, llagas en la boca o úlceras genitales.¿Cómo se pueden prevenir el herpes y el VIH? ...
... Health Services Administration
Focus on the Liver: Alcohol Use, Highly Active Antiretroviral Therapy, and Liver Disease in HIV-Infected Patients — National Institute on Alcohol Abuse and Alcoholism
Focus on the Heart: Alcohol Consumption, HIV Infection, and Cardiovascular Disease — National Institute on Alcohol Abuse and Alcoholism
Alcohol ...
El alcohol y el VIH: su guía
... Health Services Administration
Focus on the Liver: Alcohol Use, Highly Active Antiretroviral Therapy, and Liver Disease in HIV-Infected Patients — National Institute on Alcohol Abuse and Alcoholism
Focus on the Heart: Alcohol Consumption, HIV Infection, and Cardiovascular Disease — National Institute on Alcohol Abuse and Alcoholism
Alcohol ...
... El periodo de ventana —es decir, el tiempo que debe pasar para que la prueba pueda detectar la infección con precisión— va de los 23 a los 90 días después del contagio.Si su prueba de anticuerpos sale no reactiva, significa que no se detectaron anticuerpos del VIH en su muestra de sangre.Esta prueba podría no detectar el VIH con precisión si se la realiza ...
¿Qué significa un resultado no reactivo en la prueba del VIH? Entienda sus resultados
... El periodo de ventana —es decir, el tiempo que debe pasar para que la prueba pueda detectar la infección con precisión— va de los 23 a los 90 días después del contagio.Si su prueba de anticuerpos sale no reactiva, significa que no se detectaron anticuerpos del VIH en su muestra de sangre.Esta prueba podría no detectar el VIH con precisión si se la realiza ...
únete
